Skip to main content

Table 2 Antimicrobial susceptibility profile of K. pneumoniae isolates

From: Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran

Susceptibility profile

SXT

CTX

FEP

AN

IPM

MEM

CRO

GM

CAZ

CIP

MDR

S

25 (37.3%)

26 (38.8%)

27 (40.3%)

55 (82.1%)

41 (61.2%)

38 (56.7%)

29 (43.3%)

48 (71.6%)

28 (41.7%)

19 (28.3%)

I

4 (5.9%)

8 (11.9%)

5 (7.5%)

5 (7.5%)

2 (2.9%)

1 (1.5%)

9 (13.4%)

2 (2.9%)

8 (11.9%)

4 (5.9%)

R

38 (56.7%)

33 (49.3%)

35 (52.2%)

7 (10.4%)

24 (35.8%)

28 (41.7%)

29 (43.3%)

17 (25.4%)

31 (46.3%)

44 (65.6%)

Non-MDR

S

18 (54.5%)

22 (66.6%)

22 (66.6%)

31 (93.9%)

22 (66.6%)

23 (69.6%)

16 (48.5%)

25 (75.5%)

18 (54.5%)

19 (57.5%)

I

1 (3%)

4 (12.1%)

3 (9.1%)

2 (6.1%)

0 (0.0%)

1 (3%)

3 (9.1%)

0 (0.0%)

2 (6.1%)

5 (15.2%)

R

14 (42.4%)

18 (54.5%)

8 (24.2%)

0 (0.0%)

11 (33.3%)

9 (27.3%)

14 (42.4%)

8 (24.2%)

13 (39.4%)

9 (27.3%)

  1. MDR multidrug resistant, S susceptible, I intermediate resistant, R resistant, SXT Trimethoprim-sulfamethoxazole, CTX cefotaxime, FEP cefepime, AN amikacin, IPM imipenem, MEM meropenem, CRO ceftriaxone, GM gentamicin, CAZ ceftazidime, and CIP ciprofloxacin